Use of Routine Soil Tests to Estimate Pb Bioaccessibility.
Soil lead (Pb) hazard level is contingent on bioavailability, but existing assays that estimate Pb bioavailability for human health risks are too expensive or otherwise inaccessible to many people that are impacted by Pb-contaminated soil. This study investigated the use of routine soil nutrient tests to estimate soil-Pb bioaccessibility as a surrogate measure of Pb bioavailability. A silt loam soil was spiked to a target concentration of 2000 mg Pb kg-1 with Pb(NO3)2 and amended with H3PO4 (varying P-to-Pb molar ratios) and KCl (Cl-to-P molar ratio of 2:5) to generate soils with similar total Pb concentrations but a range of Pb bioavailability (and bioaccessibility). Soils were extracted using Mehlich 3, Mehlich 1, Bray P1, Olsen, and micronutrient (DTPA) methods, and the results were compared to U.S. Environmental Protection Agency method 1340 data as well as to extended X-ray absorption fine structure (EXAFS) spectroscopy. The Mehlich 3 and method 1340 treatment effect ratios were well-correlated ( r2 = 0.88, p ≤ 0.05), whereas Bray P1, DTPA, and Olsen results were more reflective of EXAFS data. Preliminary animal-feeding trials suggest that the Mehlich 3 is as effective as method 1340 at predicting the impact of P treatment on Pb relative bioavailability; however, both methods over-estimated the Pb hazard to mice in P-amended soil. Other routine soil tests that have heightened sensitivity to P amendment (e.g., Bray P1) may be promising candidates for Pb bioaccessibility assessment.